Watanabe, Tatsuro <br/><br/>
Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.  [electronic resource] 

 -  Anticancer research  Jan 2016 
 - 95-102 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Etoposide--pharmacology<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Leukemia-Lymphoma, Adult T-Cell--drug therapy<br/>Mechanistic Target of Rapamycin Complex 1<br/>Mechanistic Target of Rapamycin Complex 2<br/>Multiprotein Complexes--antagonists & inhibitors<br/>Naphthyridines--pharmacology<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors